101 related articles for article (PubMed ID: 27035928)
41. Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.
Krane JF; Cibas ES; Alexander EK; Paschke R; Eszlinger M
Cancer Cytopathol; 2015 Jun; 123(6):356-61. PubMed ID: 25926393
[TBL] [Abstract][Full Text] [Related]
42. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
43. Validation of a five-tier cytodiagnostic system for thyroid fine needle aspiration biopsies using cytohistologic correlation.
Yoder BJ; Redman R; Massoll NA
Thyroid; 2006 Aug; 16(8):781-6. PubMed ID: 16910881
[TBL] [Abstract][Full Text] [Related]
44. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
[TBL] [Abstract][Full Text] [Related]
45. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
[TBL] [Abstract][Full Text] [Related]
46. Fine-needle aspiration cytology of thyroid nodules--how well are we doing?
Cheung YS; Poon CM; Mak SM; Suen MW; Leong HT
Hong Kong Med J; 2007 Feb; 13(1):12-5. PubMed ID: 17277386
[TBL] [Abstract][Full Text] [Related]
47. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis of thyroid cancer: state of art.
Boufraqech M; Patel D; Xiong Y; Kebebew E
Expert Opin Med Diagn; 2013 Jul; 7(4):331-42. PubMed ID: 23701167
[TBL] [Abstract][Full Text] [Related]
49. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches.
Corrias A; Einaudi S; Chiorboli E; Weber G; Crinò A; Andreo M; Cesaretti G; de Sanctis L; Messina MF; Segni M; Cicchetti M; Vigone M; Pasquino AM; Spera S; de Luca F; Mussa GC; Bona G
J Clin Endocrinol Metab; 2001 Oct; 86(10):4644-8. PubMed ID: 11600519
[TBL] [Abstract][Full Text] [Related]
50. Experience with standardized thyroid fine-needle aspiration reporting categories: follow-up data from 529 cases with "indeterminate" or "atypical" reports.
Nga ME; Kumarasinghe MP; Tie B; Sterrett GF; Wood B; Walsh J; Nguyen H; Whyte A; Frost FA
Cancer Cytopathol; 2010 Dec; 118(6):423-33. PubMed ID: 20945329
[TBL] [Abstract][Full Text] [Related]
51. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.
Chang H; Lee H; Yoon SO; Kim H; Kim A; Kim BH
Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961
[TBL] [Abstract][Full Text] [Related]
52. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.
Zatelli MC; Trasforini G; Leoni S; Frigato G; Buratto M; Tagliati F; Rossi R; Cavazzini L; Roti E; degli Uberti EC
Eur J Endocrinol; 2009 Sep; 161(3):467-73. PubMed ID: 19574281
[TBL] [Abstract][Full Text] [Related]
53. Proteomics for the diagnosis of thyroid lesions: preliminary report.
Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
[TBL] [Abstract][Full Text] [Related]
54. Using gene expression profiling to differentiate benign versus malignant thyroid tumors.
Mazzanti C; Zeiger MA; Costouros NG; Umbricht C; Westra WH; Smith D; Somervell H; Bevilacqua G; Alexander HR; Libutti SK
Cancer Res; 2004 Apr; 64(8):2898-903. PubMed ID: 15087409
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes.
Jia M; Li Z; Pan M; Tao M; Lu X; Liu Y
Life Sci; 2020 Oct; 259():118248. PubMed ID: 32791153
[TBL] [Abstract][Full Text] [Related]
56. Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer.
Bastman JJ; Serracino HS; Zhu Y; Koenig MR; Mateescu V; Sams SB; Davies KD; Raeburn CD; McIntyre RC; Haugen BR; French JD
J Clin Endocrinol Metab; 2016 Jul; 101(7):2863-73. PubMed ID: 27045886
[TBL] [Abstract][Full Text] [Related]
57. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
[TBL] [Abstract][Full Text] [Related]
58. The role of Na
Holmberg SR; Sakamoto Y; Kato A; Romero MF
Pflugers Arch; 2024 Apr; 476(4):479-503. PubMed ID: 38536494
[TBL] [Abstract][Full Text] [Related]
59. Artificial intelligence defines protein-based classification of thyroid nodules.
Sun Y; Selvarajan S; Zang Z; Liu W; Zhu Y; Zhang H; Chen W; Chen H; Li L; Cai X; Gao H; Wu Z; Zhao Y; Chen L; Teng X; Mantoo S; Lim TK; Hariraman B; Yeow S; Alkaff SMF; Lee SS; Ruan G; Zhang Q; Zhu T; Hu Y; Dong Z; Ge W; Xiao Q; Wang W; Wang G; Xiao J; He Y; Wang Z; Sun W; Qin Y; Zhu J; Zheng X; Wang L; Zheng X; Xu K; Shao Y; Zheng S; Liu K; Aebersold R; Guan H; Wu X; Luo D; Tian W; Li SZ; Kon OL; Iyer NG; Guo T
Cell Discov; 2022 Sep; 8(1):85. PubMed ID: 36068205
[TBL] [Abstract][Full Text] [Related]
60. Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration.
Shih ML; Lawal B; Cheng SY; Olugbodi JO; Babalghith AO; Ho CL; Cavalu S; Batiha GE; Albogami S; Alotaibi SS; Lee JC; Wu ATH
Front Cell Dev Biol; 2022; 10():923503. PubMed ID: 35990603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
